ANGO Earnings & Financial Statements
AngioDynamics, Inc.
$11.05
+$0.15(+1.38%)
45
Overall
60
Value
27
Tech
50
Quality
Market Cap
$464.70M
Volume
1.59M
52W Range
$9.39 - $16.29
Target Price
$19.00
ANGO earnings and financial statements: AngioDynamics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ANGO Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $320.17M | $292.50M | $303.91M | $338.75M | $316.22M |
| Cost of revenue | -$145.28M | -$134.79M | $149.22M | $164.51M | $150.49M |
| Operating income | -$39.93M | -$39.95M | -$192.44M | -$51.18M | -$28.47M |
| EBITDA | -$13.93M | -$9.13M | -$165.54M | -$20.86M | $88.0K |
| Net income | -$36.74M | -$33.99M | -$184.35M | -$52.44M | -$26.55M |
| EPS (diluted) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $267.16M | $280.14M | $317.67M | $532.64M | $552.75M |
| Total liabilities | $96.34M | $97.17M | $112.08M | $154.34M | $128.26M |
| Shareholders’ equity | $170.82M | $182.97M | $205.59M | $378.30M | $424.49M |
| Cash and equivalents | $53.86M | $55.89M | $76.06M | $44.62M | $28.82M |
| Long-term debt | - | - | - | $49.82M | $25.00M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $3.09M | -$10.13M | -$28.16M | $78.0K | -$7.19M |
| Capital expenditure | -$2.58M | -$4.46M | -$5.77M | -$4.35M | -$4.30M |
| Free cash flow | $508.0K | -$14.59M | -$30.68M | -$4.27M | -$11.49M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANGO | $11.05 | +1.4% | 1.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |